Amsterdam institute for Immunology and Infectious diseases
-
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome
Groen, K., Smits, F., Nasserinejad, K., Levin, M.-D., Regelink, J. C., Timmers, G.-J., de Waal, E. G. M., Westerman, M., Velders, G. A., de Heer, K., Leys, R. B. L., van Kampen, R. J. W., Stege, C. A. M., Seefat, M. R., Nijhof, I. S., van der Spek, E., Klein, S. K., van de Donk, N. W. C. J., Ypma, P. F. & Zweegman, S., 1 Dec 2025, In: HemaSphere. 9, 12, e70268.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial
Smits, F., Groen, K., Levin, M.-D., Stege, C. A. M., van Kampen, R., van der Spek, E., Nijhof, I., Bilgin, Y. M., Thielen, N., Ludwig, I., de Waal, E. G. M., Sandberg, Y., Kentos, A., Timmers, G.-J., Regelink, J. C., Westerman, M., de Heer, K., Vekemans, M.-C., Durdu-Rayman, N. & HOVON 143 Study Group, 25 Nov 2025, In: Blood. 9, 22, p. 5828-5836 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines
Pothast, C. R., Hofsink, Q., Haggenburg, S., Dijkland, R. C., van de Meent, M., van Dijk, K., Bhoekhan, M. S., Haverkate, N. J. E., van Meerloo, J., Falkenburg, J. H. F., de Groen, R. A. L., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., Kater, A. P., Smits, G. P., Wouters, D. & van Leeuwen, E. M. M. & 13 others, , 1 Nov 2025, In: Haematologica. 110, 11, p. 2799-2805Research output: Contribution to journal › Article › Academic › peer-review
- All publications